主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RANI
#3481
Rani Therapeutics Holdings, Inc. Class A Common Stock
1.3
7
-0.72%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.72%
每月变动
-0.72%
6个月变化
+140.35%
年变化
-8.67%
前一天收盘价
1.3
8
Open
1.3
7
Bid
Ask
Low
1.3
7
High
1.3
7
交易量
19
市场
股票
医疗保健
RANI
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
24.39 M
25.3 M
26.04 M
33.51 M
—
Valuation ratios
Enterprise value
3.17 B
1.18 B
682.83 M
312.74 M
—
Price to earnings ratio
—
-4.61
-2.53
-1.3
-3.62
Price to sales ratio
—
—
—
0.04
—
Price to cash flow ratio
—
-3.02
-1.68
-1.1
-3.24
Price to book ratio
—
3.81
6.68
19.58
16.66
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.28
0.59
0.82
1.48
Return on equity %
0.07
0.41
1.34
8.59
5.1
Return on invested capital %
4 359.55
3 939.3
895.26
523.42
—
Gross margin %
100
—
—
100
—
Operating margin %
1 899.12
—
—
5 186.19
—
EBITDA margin %
—
—
—
—
—
Net margin %
306.62
—
—
2 920.04
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
45.3
20.96
6.36
1.5
3.17
Inventory turnover
—
—
—
—
—
Asset turnover
0.02
0
—
0.02
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0.27
0.42
0.26
0.64
Long term debt to total equity ratio
0
0.79
1.9
4.83
7.16
Per share metrics
Operating cash flow per share
—
1.95
2.01
1.25
0.81
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
5.27
0.23
0.13
0.8
Net current asset value per share
—
4.24
1.99
1.04
1.99
Tangible book value per share
—
1.55
0.5
0.07
0.48
Working capital per share
—
4.04
1.68
0.35
-0.29
Book value per share
—
1.55
0.5
0.07
0.48
新闻
Rani Therapeutics任命Alireza Javadi为首席技术官
Rani Therapeutics promotes Alireza Javadi to chief technical officer
Rani Therapeutics begins phase 1 trial of oral obesity treatment
Rani Therapeutics修改公司章程,降低B类股投票权并终止税务协议
Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement
Rani Therapeutics宣布与中外制药达成价值10.85亿美元合作协议
Rani Therapeutics announces $1.085 billion Chugai collaboration
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%
美国股市上涨;截至收盘道琼斯工业平均指数上涨0.09%
Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27
Rani Therapeutics董事Imran Mir A购入价值126万美元股票
Rani Therapeutics director Imran Mir a buys $1.26 million in stock